Cover Image
市場調查報告書

正子斷層掃描 (PET) 設備的全球市場:醫療設備的開發平台評估

Positron Emission Tomography (PET) Systems - Medical Devices Pipeline Assessment, 2016

出版商 GlobalData 商品編碼 358892
出版日期 內容資訊 英文 50 Pages
訂單完成後即時交付
價格
Back to Top
正子斷層掃描 (PET) 設備的全球市場:醫療設備的開發平台評估 Positron Emission Tomography (PET) Systems - Medical Devices Pipeline Assessment, 2016
出版日期: 2016年06月01日 內容資訊: 英文 50 Pages
簡介

本報告提供全球正子斷層掃描 (以下簡稱PET) 系統市場上的主要開發中產品 (醫療設備) 及其臨床實驗的進展調查,再加上產品的功能·特性比較分析 (臨床實驗的各進展階段) ,再彙整主要企業簡介及代表性產品,近來的市場動靜 (業績報告·資本交易趨勢等) 資訊,為您概述為以下內容。

第1章 目錄

第2章 簡介

  • 正子斷層掃描 (PET) 系統概要

第3章 臨床實驗中的產品

  • 開發中產品:各臨床實驗階段
  • 開發中產品:各地區
  • 開發中產品:各法規途徑
  • 開發中產品:各估計認證時期
  • 現在進行中的臨床實驗

第4章 臨床實驗中的開發中產品:各企業

  • PET設備的企業:各臨床實驗階段的開發中產品
  • PET設備:各臨床實驗階段的開發中產品

第5章 PET設備市場:企業·產品概要

  • Brain Biosciences Inc
    • 開發中產品及進行中的臨床實驗概要
  • GE Healthcare Limited
  • Jagiellonian University
  • Philips Healthcare
  • Ray Vision Intl Corp.
  • Stanford University
  • SynchroPET
  • The University of British Columbia
  • Zecotek Photonics Inc.

第6章 PET設備市場:目前的趨勢

第7章 附錄

圖表一覽

目錄
Product Code: GDME0199EPD

GlobalData's Medical Devices sector report, "Positron Emission Tomography (PET) Systems - Medical Devices Pipeline Assessment, 2016" provides an overview of Positron Emission Tomography (PET) Systems currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Positron Emission Tomography (PET) Systems pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Positron Emission Tomography (PET) Systems under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Positron Emission Tomography (PET) Systems and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Positron Emission Tomography (PET) Systems under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Positron Emission Tomography (PET) Systems Overview

3. Products under Development

  • 3.1. Positron Emission Tomography (PET) Systems - Pipeline Products by Stage of Development
  • 3.2. Positron Emission Tomography (PET) Systems - Pipeline Products by Territory
  • 3.3. Positron Emission Tomography (PET) Systems - Pipeline Products by Regulatory Path
  • 3.4. Positron Emission Tomography (PET) Systems - Pipeline Products by Estimated Approval Date
  • 3.5. Positron Emission Tomography (PET) Systems - Ongoing Clinical Trials

4. Positron Emission Tomography (PET) Systems - Pipeline Products under Development by Companies

  • 4.1. Positron Emission Tomography (PET) Systems Companies - Pipeline Products by Stage of Development
  • 4.2. Positron Emission Tomography (PET) Systems - Pipeline Products by Stage of Development

5. Positron Emission Tomography (PET) Systems Companies and Product Overview

  • 5.1. Brain Biosciences Inc Company Overview
    • 5.1.1. Brain Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. GE Healthcare Limited Company Overview
    • 5.2.1. GE Healthcare Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. Jagiellonian University Company Overview
    • 5.3.1. Jagiellonian University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. Philips Healthcare Company Overview
    • 5.4.1. Philips Healthcare Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. Ray Vision Intl Corp. Company Overview
    • 5.5.1. Ray Vision Intl Corp. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6. Stanford University Company Overview
    • 5.6.1. Stanford University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7. SynchroPET Company Overview
    • 5.7.1. SynchroPET Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8. The University of British Columbia Company Overview
    • 5.8.1. The University of British Columbia Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9. Zecotek Photonics Inc. Company Overview
    • 5.9.1. Zecotek Photonics Inc. Pipeline Products & Ongoing Clinical Trials Overview

6. Positron Emission Tomography (PET) Systems- Recent Developments

  • 6.1. May 27, 2016: FDA approves new diagnostic imaging agent to detect recurrent prostate cancer
  • 6.2. May 26, 2016: Advanced Accelerator Applications to Acquire Two Production Sites in Germany
  • 6.3. May 26, 2016: Advanced Accelerator Applications Appoints Francois Nader, M.D., to Board of Directors
  • 6.4. May 25, 2016: FluoroPharma Medical Announces Acceptance of CardioPET Data for Presentation at the 21st Scientific Meeting of the American Society of Nuclear Cardiology
  • 6.5. May 24, 2016: PET imaging with special tracer can detect and diagnose early Alzheimer's disease
  • 6.6. May 18, 2016: Itel Telecomunicazioni Enters into Agreement with Advanced Accelerator Applications
  • 6.7. Apr 29, 2016: Advanced Accelerator Applications reports 26.8% sales growth in 2015 and continues to show significant clinical progress across both therapeutic and diagnostic platforms
  • 6.8. Apr 21, 2016: CERN Orders LFS Crystals
  • 6.9. Apr 11, 2016: PET scans guiding chemo boosts remission for Hodgkin patients
  • 6.10. Apr 06, 2016: First Patent Received for New LFS Crystal Formulation
  • 6.11. Apr 01, 2016: Zecotek Announces Significant Opportunity for LFS Scintillation Crystals and Enters Radiation Safety and Homeland Security Market Due to World Events and Demand by OEMs
  • 6.12. Mar 23, 2016: FluoroPharma Medical Raises USD0.15 Million in Private Placement of Notes
  • 6.13. Mar 23, 2016: Chinese OEM Adopts Zecotek's LFS Scintillation Crystal for New Line of Positron Emission Tomography Medical Scanning Devices
  • 6.14. Jan 26, 2016: Zevacor to Produce SomaKit-TATE Doses for AAA
  • 6.15. Dec 29, 2015: FluoroPharma Names Dr. Thomas Tulip, PhD Chief Executive Officer
  • 6.16. Dec 14, 2015: CapVest Partners Acquires IBA Molecular from Ion Beam Applications and SK Capital Partners for USD69.6 Million
  • 6.17. Dec 10, 2015: Advanced Accelerator Applications Reports 37% Growth in Sales for the Third Quarter of 2015 and 32% Growth in Sales for the First Nine Months of 2015
  • 6.18. Dec 10, 2015: Zecotek Enters New Market for LFS Crystals
  • 6.19. Nov 30, 2015: IBA Molecular North America to become Zevacor Pharma
  • 6.20. Nov 05, 2015: Zecotek Receives $250,000 LFS Scintillation Crystal Order
  • 6.21. Oct 23, 2015: Nanyang Technological University Enters into Research Agreement with Austrian Institute of Technology and Medical University of Vienna
  • 6.22. Sep 17, 2015: University of California Successfully Tests Zecotek's LFS Scintillation Crystals for High Resolution Positron Emission Tomography Scanning
  • 6.23. Jul 28, 2015: JMC Investment Acquires Majority Stake in Keosys
  • 6.24. Jun 15, 2015: Advanced Accelerator Applications reports over 24% growth in sales for the first quarter of 2015

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Positron Emission Tomography (PET) Systems - Pipeline Products by Stage of Development
  • Table 2: Positron Emission Tomography (PET) Systems - Pipeline Products by Territory
  • Table 3: Positron Emission Tomography (PET) Systems - Pipeline Products by Regulatory Path
  • Table 4: Positron Emission Tomography (PET) Systems - Pipeline Products by Estimated Approval Date
  • Table 5: Positron Emission Tomography (PET) Systems - Ongoing Clinical Trials
  • Table 6: Positron Emission Tomography (PET) Systems Companies - Pipeline Products by Stage of Development
  • Table 7: Positron Emission Tomography (PET) Systems - Pipeline Products by Stage of Development
  • Table 8: Brain Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 9: CerePET - Product Status
  • Table 10: CerePET - Product Description
  • Table 11: GE Healthcare Limited Pipeline Products & Ongoing Clinical Trials Overview
  • Table 12: Q.Clear - Product Status
  • Table 13: Q.Clear - Product Description
  • Table 14: Jagiellonian University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 15: Positron Emission Tomography System - Product Status
  • Table 16: Positron Emission Tomography System - Product Description
  • Table 17: Philips Healthcare Pipeline Products & Ongoing Clinical Trials Overview
  • Table 18: Additional PET Scan - Product Status
  • Table 19: Additional PET Scan - Product Description
  • Table 20: Philips Healthcare - Ongoing Clinical Trials Overview
  • Table 21: Additional PET Scan - Pilot Study Intended to Provide Input for Future Designs Using the PET Alpha Ring Detector and to Support the Pre-market Notification of a Future Product
  • Table 22: Ray Vision Intl Corp. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 23: Helmet - PET System - Product Status
  • Table 24: Helmet - PET System - Product Description
  • Table 25: Stanford University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 26: Breast-Dedicated PET System - Product Status
  • Table 27: Breast-Dedicated PET System - Product Description
  • Table 28: Dual Panel PET Scanner - Product Status
  • Table 29: Dual Panel PET Scanner - Product Description
  • Table 30: Dual-isotope Positron Emitting Tomography System - Product Status
  • Table 31: Dual-isotope Positron Emitting Tomography System - Product Description
  • Table 32: Improved PET System - Product Status
  • Table 33: Improved PET System - Product Description
  • Table 34: MR Compatible PET System - Product Status
  • Table 35: MR Compatible PET System - Product Description
  • Table 36: PET Sensitivity Enhancing Device - Product Status
  • Table 37: PET Sensitivity Enhancing Device - Product Description
  • Table 38: SynchroPET Pipeline Products & Ongoing Clinical Trials Overview
  • Table 39: Breast PET-MRI - Product Status
  • Table 40: Breast PET-MRI - Product Description
  • Table 41: Wrist Scanner - Product Status
  • Table 42: Wrist Scanner - Product Description
  • Table 43: The University of British Columbia Pipeline Products & Ongoing Clinical Trials Overview
  • Table 44: PET Imaging Tool - Product Status
  • Table 45: PET Imaging Tool - Product Description
  • Table 46: Zecotek Photonics Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 47: New Generation PET Scanning Device - Product Status
  • Table 48: New Generation PET Scanning Device - Product Description
  • Table 49: Glossary

List of Figures

  • Figure 1: Positron Emission Tomography (PET) Systems - Pipeline Products by Stage of Development
  • Figure 2: Positron Emission Tomography (PET) Systems - Pipeline Products by Territory
  • Figure 3: Positron Emission Tomography (PET) Systems - Pipeline Products by Regulatory Path
  • Figure 4: Positron Emission Tomography (PET) Systems - Pipeline Products by Estimated Approval Date
  • Figure 5: Positron Emission Tomography (PET) Systems - Ongoing Clinical Trials
Back to Top